Curist Pharma
Curist Pharma is a Ghana-based, pre-launch pharmaceutical company building an integrated pharmaceutical value-chain business. Led by a four-person C-suite, the company has not yet disclosed products, customers, or revenue, with its website currently displaying a 'Launching Soon' placeholder.
- Company typePrivate
- Founded2010
- HeadquartersAccra, Ghana
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Curist Pharma does
Curist Pharma is a Ghana-headquartered, private pharmaceutical company that, according to its own short description, positions itself as an integrated value-chain pharmaceutical business. The company is nominally founded in 2010 and operates with a small team of 1-10 employees based in Accra. Its public-facing presence is limited to a website (curistpharma.com) that currently displays a 'Launching Soon' placeholder, an email signup form for launch updates and promotions, and a 2026 copyright notice, suggesting either recent formation or a forthcoming reactivation after a long dormant period. There is no disclosed product portfolio, service offering, manufacturing capability, therapeutic area focus, or distribution footprint.
The company's leadership bench comprises a full C-suite: David Frempong Addo as CEO and Director, Abigail Afriyie Abora Addo as COO and Deputy CEO, Sylvia Adjoa Lawson as CFO, and Raj Saibu Tamanjah as CMO. On the capital side, the only documented funding event is a 2015-12-11 round led by Synergy Capital Managers with an undisclosed (recorded as $0) investment amount, and no subsequent rounds, revenue figures, customer logos, partnerships, patents, certifications, or regulatory registrations are publicly disclosed. No technology stack, AI capabilities, apps, APIs, or proprietary platforms are described.
The business model is not yet operational or publicly defined: pricing is not disclosed, the company appears to be in a pre-launch or launch-imminent phase, and the go-to-market motion (wholesale distribution, retail pharmacy, hospital supply, manufacturing, import) cannot be determined from available source data. Geographic scope beyond Ghana is not articulated, and there is no evidence of active sales, distribution agreements, or licensing arrangements.
Curist Pharma firmographics
Firmographics- Name
- Curist Pharma
- Legal name
- curistpharma.com
- Website
- https://curistpharma.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Curist Pharma is a Ghana-based, pre-launch pharmaceutical company building an integrated pharmaceutical value-chain business. Led by a four-person C-suite, the company has not yet disclosed products, customers, or revenue, with its website currently displaying a 'Launching Soon' placeholder.
- Ownership category
- akta.pro rank
Curist Pharma industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmacies and Drug Retailers (45611), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Retail & Community Pharmacies (Chain/Independent) (HLAFALAA)
Keywords
Where Curist Pharma is headquartered
LocationHeadquarters
- HQ city
- Accra
- HQ country
- Ghana
- HQ region
- Africa
Markets served
Curist Pharma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Marketing channels1 record
Curist Pharma product offering
Product offeringCore offering
Curist Pharma is described as a fast-growing pharmaceutical integrated value chain business. The company has not yet publicly launched; its website displays a 'Launching Soon' placeholder with no product or service details disclosed. The intended offering covers pharmaceutical products across an integrated value chain, but specific categories, formulations, or therapeutic areas are not specified.
Product overview
Curist Pharma is a pharmaceutical company whose official website currently displays only a 'Launching Soon' placeholder page. No product portfolio, named offerings, or service details are available on the current site.
Differentiator
Problem solved
Functional benefit
Companies that use Curist Pharma
Customer profileIdeal customer profiles2 records
Curist Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Curist Pharma partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights4 records
Curist Pharma competitors and assessment
Company assessmentDirect peers
- mPharma: mPharma is a Ghana-headquartered pharma company that manages an integrated supply, retail, and patient-affordability platform across Africa. Directly comparable to Curist given shared Ghana base and integrated pharma value-chain model.
- Tobinco Pharmaceuticals: Tobinco is a leading Ghanaian pharmaceutical manufacturer and distributor with branded generics across multiple therapy areas. Comparable to Curist as a vertically integrated Ghana pharma operator targeting similar local demand.
- Dannex Ayrton Star Pharmaceuticals: Dannex Ayrton Star is one of Ghana's largest local pharma manufacturers and distributors. Directly comparable to Curist given overlapping focus on Ghanaian manufacturing and distribution of essential medicines.
- Ernest Chemists Limited: Ernest Chemists is a long-established Ghanaian pharmaceutical manufacturer and distributor. Comparable to Curist as a domestic Ghanaian pharma player with manufacturing and distribution operations.
Regional players
- PharmaEthics Nigeria: PharmaEthics is a Nigerian pharma manufacturer with a growing distribution footprint in West Africa. Comparable to Curist as a regional integrated pharma player targeting similar therapeutic categories and customer types across neighboring markets.
- Emzor Pharmaceutical Industries: Emzor is one of Nigeria's largest indigenous pharmaceutical manufacturers with branded generics across multiple categories. Comparable to Curist as an African integrated pharma operator pursuing similar mass-market therapeutic segments.
- Aspen Pharmacare: Aspen Pharmacare is Africa's largest pharmaceutical manufacturer with branded and generic portfolios across the continent. Comparable to Curist as an integrated pharma value-chain operator serving sub-Saharan markets.
Broad incumbents
- Cipla: Cipla is a global generics manufacturer with a strong presence in Africa including branded ARVs, respiratory, and OTC products. Comparable to Curist as a vertically capable pharma company competing for the same African prescriber and patient base.
- Novartis: Novartis is a global pharmaceutical major with significant Africa operations across branded and generics divisions. Comparable to Curist as a competitor for the same prescriber and patient pools in Ghana and West Africa.
- GSK: GSK is a global pharmaceutical company with established distribution and consumer health operations across Africa. Comparable to Curist as a multinational competitor active in Ghanaian pharma retail and prescription channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights4 records
Customer concentration
Curist Pharma social profiles
Digital presenceCurist Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curist Pharma leadership team
Management profileNumber of profiles
Profiles4 records
Curist Pharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curist Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curist Pharma
What does Curist Pharma do?
Curist Pharma is described as a fast-growing pharmaceutical integrated value chain business. The company has not yet publicly launched; its website displays a 'Launching Soon' placeholder with no product or service details disclosed. The intended offering covers pharmaceutical products across an integrated value chain, but specific categories, formulations, or therapeutic areas are not specified.
When was Curist Pharma founded?
Curist Pharma was founded in 2010. It employs 1 to 10 people.
Where is Curist Pharma based?
Curist Pharma is headquartered in Accra, Ghana, in the Africa region.
Who are Curist Pharma's main competitors?
Direct peers on record are mPharma, Tobinco Pharmaceuticals, Dannex Ayrton Star Pharmaceuticals and Ernest Chemists Limited. Regional players are PharmaEthics Nigeria, Emzor Pharmaceutical Industries and Aspen Pharmacare. Broad incumbents are Cipla, Novartis and GSK.
Does Curist Pharma have an API?
No public API is recorded for Curist Pharma.
What industry is Curist Pharma in?
Curist Pharma's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAFALAA, Retail & Community Pharmacies (Chain/Independent). Its NAICS code is 45611 and its SIC code is 5912.